Delivery Order SPE2DB20D3505-SPE2DB24FU7J4
Award Date
8/2/24
Potential Completion Date
8/5/24
Potential Value
$4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Ondansetron HCl 8 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $15,314.72, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of February 6, 2024, and was awarded on February 5, 2024. This appears to be a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is...
This federal contract award is for the delivery of Ondansetron HCL 8 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a ceiling value of $4,368.15. The contract is a delivery order with a firm fixed price pricing type, with an ultimate completion date of May 28, 2025. There is no set-aside designation mentioned for this contract....
This federal contract award is for the delivery of Ondansetron HCL 4 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $3,263.59, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of December 14, 2023. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
This federal contract award is for the delivery of Ondansetron ODT 8 mg tablets in quantities of 30s. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is a delivery order with a firm fixed price of $4,452.96 and a completion date of June 9, 2025. The contract is not set aside for any particular business type. Amerisourcebergen Drug Corp is the...
This federal contract award, valued at $1,987.45, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order to supply 4562549431 - Ondansetron HCL 8 mg Tablets to DLA. The contract has a firm fixed price and an ultimate completion date of October 23, 2023. This award is not a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award is for the delivery of Ondansetron HCL 4 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $17,460.11 and is a firm fixed-price delivery order, awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of April 24, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a substantial Indefinite...
This federal contract award is for the delivery of Ondansetron ODT 8 mg tablet 30s, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $6,351.25 fixed-price contract with a completion date of May 9, 2024 was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award is for the delivery of Ondansetron HCL 8 mg tablets to the Defense Logistics Agency (DLA). The $9,232.09 delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a firm fixed price pricing type and no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
The federal contract award is for the delivery of Ondansetron ODT 8 mg tablets in quantities of 30 to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $1,647.94 and is a firm fixed-price delivery order. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp also holds a...
This federal contract award is for the delivery of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA). The $1,940.22 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on March 6, 2025. The contract has a completion date of March 7, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...